We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Cardiology

You are here

INCREASE 202:  An Open-label extension study of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease (INCREASE RIN-PH-202)

IRB Protocol #: 1705018243

Overview: The purpose of this research study is to provide or continue to provide inhaled treprostinil to eligible subjects who participated in the RIN-PH-201 study.  This trial is funded by United Therapeutics.

Contact:

Dr. Irina Sobol
Principle Investigator
Email: irs9009@med.cornell.edu
Phone: (212) 746-2381

Melissa Ricketts, MSHS, CCRC
Research Coordinator
Email: mdr2001@med.cornell.edu
Phone: (212) 746-2698

Make an Appointment

(646) 962-5558

Weill Cornell Medicine
Division of Cardiology

520 East 70th Street
Starr 443
New York, NY 10021

1305 York Avenue, 8th Floor
New York, NY 10021